SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662579-24-000037
Filing Date
2024-04-02
Accepted
2024-04-02 16:34:29
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1712090040.html 4  
1 FORM 4 wk-form4_1712090040.xml 4 5772
  Complete submission text file 0001662579-24-000037.txt   7277
Mailing Address C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC 40 WEST 57TH STREET, 32ND FLOOR NEW YORK NY 10019
Business Address
Dubin Glenn (Reporting) CIK: 0001308597 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 24814873

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)